Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Celcuity (CELC) Financials

Celcuity logo
$49.46 +0.21 (+0.43%)
Closing price 08/26/2025 04:00 PM Eastern
Extended Trading
$49.52 +0.06 (+0.13%)
As of 07:35 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Celcuity

Annual Income Statements for Celcuity

This table shows Celcuity's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 -3.31 -6.25 -7.48 -7.36 -9.47 -30 -40 -64 -112
Consolidated Net Income / (Loss)		 -3.31 -6.25 -7.48 -7.36 -9.47 -30 -40 -64 -112
Net Income / (Loss) Continuing Operations		 -3.31 -6.25 -7.48 -7.36 -9.47 -30 -40 -64 -112
Total Pre-Tax Income 		-3.31 -6.25 -7.48 -7.36 -9.47 -30 -40 -64 -112
Total Operating Income		 -3.33 -5.95 -7.93 -7.81 -9.56 -28 -39 -66 -113
Total Gross Profit		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Revenue		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Cost of Revenue		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Operating Expenses		 3.33 5.95 7.93 7.81 9.56 28 39 66 113
Selling, General & Admin Expense		 0.26 0.97 1.61 1.54 1.87 2.60 4.10 5.64 9.06
Research & Development Expense		 3.06 4.98 6.33 6.27 7.68 26 35 61 104
Total Other Income / (Expense), net		 0.02 -0.30 0.45 0.45 0.08 -1.25 -0.98 2.45 1.49
Interest Expense		 0.00 0.45 0.00 0.00 0.00 1.26 2.11 5.33 10
Interest & Investment Income		 0.02 0.15 0.45 0.45 0.08 0.01 1.13 7.78 12
Income Tax Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Basic Earnings per Share		 ($0.52) ($0.84) ($0.74) ($0.72) ($0.92) ($2.21) ($2.64) ($2.69) ($2.83)
Weighted Average Basic Shares Outstanding		 6.31M 7.46M 10.12M 10.23M 10.27M 13.38M 15.42M 23.68M 39.45M
Diluted Earnings per Share		 ($0.52) ($0.84) ($0.74) ($0.72) ($0.92) - ($2.64) ($2.69) ($2.83)
Weighted Average Diluted Shares Outstanding		 6.31M 7.46M 10.12M 10.23M 10.27M 13.38M 15.42M 23.68M 39.45M
Weighted Average Basic & Diluted Shares Outstanding		 6.31M 7.46M 10.12M 10.23M 10.27M 13.38M 21.69M 30.45M 37.84M

Quarterly Income Statements for Celcuity

This table shows Celcuity's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -11 -12 -12 -15 -18 -19 -22 -24 -30 -37 -37
Consolidated Net Income / (Loss)		 -11 -12 -12 -15 -18 -19 -22 -24 -30 -37 -37
Net Income / (Loss) Continuing Operations		 -11 -12 -12 -15 -18 -19 -22 -24 -30 -37 -37
Total Pre-Tax Income 		-11 -12 -12 -15 -18 -19 -22 -24 -30 -37 -37
Total Operating Income		 -11 -12 -13 -15 -19 -20 -22 -24 -30 -36 -36
Total Gross Profit		 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Revenue		 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Cost of Revenue		 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Operating Expenses		 11 12 13 15 19 20 22 24 30 36 36
Selling, General & Admin Expense		 1.02 1.04 1.27 1.31 1.41 1.65 1.85 1.79 2.47 2.96 3.91
Research & Development Expense		 9.62 11 11 14 17 18 21 22 28 33 32
Total Other Income / (Expense), net		 -0.25 0.06 0.61 0.47 0.49 0.88 0.88 0.56 0.54 -0.49 -0.86
Interest Expense		 0.54 0.68 1.24 1.31 1.37 1.40 1.40 2.26 3.34 3.28 3.18
Interest & Investment Income		 0.29 0.74 1.85 1.78 1.87 2.28 2.28 2.82 3.61 3.05 2.32
Income Tax Expense		 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Basic Earnings per Share		 ($0.75) ($0.69) ($0.55) ($0.66) ($0.83) ($0.65) ($0.64) ($0.62) ($0.70) ($0.87) ($0.86)
Weighted Average Basic Shares Outstanding		 14.94M 15.42M 21.68M 21.96M 22.12M 23.68M 33.61M 38.44M 42.79M 39.45M 43.05M
Diluted Earnings per Share		 ($0.75) - ($0.55) ($0.66) ($0.83) ($0.65) ($0.64) ($0.62) ($0.70) ($0.87) ($0.86)
Weighted Average Diluted Shares Outstanding		 14.94M 15.42M 21.68M 21.96M 22.12M 23.68M 33.61M 38.44M 42.79M 39.45M 43.05M
Weighted Average Basic & Diluted Shares Outstanding		 15.46M 21.69M 21.96M 22.09M 24.20M 30.45M 31.23M 37.03M 37.13M 37.84M 37.87M

Annual Cash Flow Statements for Celcuity

This table details how cash moves in and out of Celcuity's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 0.79 -3.22 13 2.79 -7.10 73 -60 6.09 -8.15
Net Cash From Operating Activities		 -2.89 -4.95 -6.08 -6.00 -7.15 -20 -36 -54 -83
Net Cash From Continuing Operating Activities		 -2.89 -4.95 -6.08 -5.66 -7.15 -20 -36 -54 -83
Net Income / (Loss) Continuing Operations		 -3.31 -6.25 -7.48 -7.36 -9.47 -30 -40 -64 -112
Consolidated Net Income / (Loss)		 -3.31 -6.25 -7.48 -7.36 -9.47 -30 -40 -64 -112
Depreciation Expense		 0.07 0.10 0.22 0.34 0.39 0.30 0.21 0.14 0.13
Amortization Expense		 - - - - 0.00 0.27 0.40 0.24 1.33
Non-Cash Adjustments To Reconcile Net Income		 0.19 1.33 1.25 1.08 1.74 7.90 4.95 5.72 8.50
Changes in Operating Assets and Liabilities, net		 0.16 -0.13 -0.07 -0.05 0.20 0.82 -1.19 3.86 18
Net Cash From Investing Activities		 -0.04 -29 19 8.53 -0.09 -0.08 -144 -5.01 -63
Net Cash From Continuing Investing Activities		 -0.04 -29 19 9.29 -0.09 -0.08 -144 -5.01 -63
Purchase of Property, Plant & Equipment		 -0.04 -0.24 -0.63 -0.38 -0.09 -0.08 -0.16 -0.10 -0.25
Purchase of Investments		 0.00 -29 -3.24 - - 0.00 -144 -315 -705
Sale and/or Maturity of Investments		 - 0.00 23 8.91 - - 0.00 310 642
Net Cash From Financing Activities		 3.72 31 0.24 0.26 0.14 93 120 65 138
Net Cash From Continuing Financing Activities		 3.72 31 0.24 0.27 0.14 93 120 65 138
Repayment of Debt		 0.00 -0.04 - - - 14 20 -0.00 0.00
Issuance of Debt		 0.00 7.49 - - 0.00 - - 0.00 59
Issuance of Common Equity		 3.72 24 0.14 0.09 0.18 0.00 96 65 64
Other Financing Activities, net		 0.00 0.00 0.10 0.18 -0.04 79 4.92 0.36 15
Cash Interest Paid		 - - - - 0.00 0.69 1.26 3.27 7.59

Quarterly Cash Flow Statements for Celcuity

This table details how cash moves in and out of Celcuity's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Change in Cash & Equivalents		 -9.43 -33 9.07 -1.40 -6.48 4.90 0.55 -0.76 -18 9.91 -6.04
Net Cash From Operating Activities		 -9.31 -9.48 -13 -9.66 -13 -19 -17 -18 -21 -28 -36
Net Cash From Continuing Operating Activities		 -9.31 -9.48 -13 -9.66 -13 -19 -17 -18 -21 -28 -36
Net Income / (Loss) Continuing Operations		 -11 -12 -12 -15 -18 -19 -22 -24 -30 -37 -37
Consolidated Net Income / (Loss)		 -11 -12 -12 -15 -18 -19 -22 -24 -30 -37 -37
Depreciation Expense		 0.05 0.05 0.04 0.04 0.03 0.03 0.03 0.03 0.03 0.04 0.04
Amortization Expense		 0.10 0.11 0.06 0.06 0.06 0.06 0.07 0.24 0.48 0.55 0.55
Non-Cash Adjustments To Reconcile Net Income		 1.33 1.14 0.01 3.47 1.09 1.15 1.64 1.32 1.71 3.83 1.75
Changes in Operating Assets and Liabilities, net		 0.10 0.80 -1.04 1.36 4.47 -0.93 2.81 4.07 7.01 4.47 -1.19
Net Cash From Investing Activities		 -0.01 -144 22 8.09 6.25 -41 3.54 -106 1.90 38 24
Net Cash From Continuing Investing Activities		 -0.01 -144 22 8.09 6.25 -41 3.54 -106 1.90 38 24
Purchase of Property, Plant & Equipment		 -0.01 -0.11 -0.01 -0.00 -0.05 -0.03 -0.09 -0.06 -0.05 -0.05 -0.06
Purchase of Investments		 - -144 -3.13 -111 -71 -130 -121 -241 -153 -190 -42
Sale and/or Maturity of Investments		 - - 25 119 77 89 125 135 155 227 67
Net Cash From Financing Activities		 -0.11 121 0.07 0.17 0.02 65 14 123 0.80 0.12 5.55
Net Cash From Continuing Financing Activities		 -0.11 121 0.07 0.17 0.02 65 14 123 0.80 0.12 5.55
Other Financing Activities, net		 -0.10 5.14 0.07 0.07 0.02 0.21 14 0.40 0.82 -0.02 5.55
Cash Interest Paid		 0.33 0.42 0.75 0.81 0.85 0.87 0.87 1.63 2.61 2.47 2.38

Annual Balance Sheets for Celcuity

This table presents Celcuity's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets		 6.06 32 26 20 13 86 176 191 245
Total Current Assets		 5.91 24 25 19 12 85 175 191 245
Cash & Equivalents		 5.86 2.64 16 19 12 84 25 31 23
Short-Term Investments		 0.00 22 8.95 - - 0.00 144 150 213
Other Current Assets		 0.01 0.03 0.05 0.05 0.02 0.04 6.60 10 9.47
Plant, Property, & Equipment, net		 0.14 0.28 0.81 0.83 0.56 0.31 0.26 0.23 0.34
Total Noncurrent Assets		 0.00 7.21 0.00 0.20 0.23 0.24 0.25 0.40 0.22
Other Noncurrent Operating Assets		 - - 0.00 0.20 0.23 0.24 0.25 0.40 0.22
Total Liabilities & Shareholders' Equity		 6.06 32 26 20 13 86 176 191 245
Total Liabilities		 0.45 0.58 0.68 0.98 1.25 17 42 51 130
Total Current Liabilities		 0.45 0.58 0.66 0.91 1.19 2.51 6.88 14 32
Accounts Payable		 0.33 0.07 0.12 0.14 0.22 1.51 2.63 5.08 9.37
Accrued Expenses		 0.11 0.51 0.54 0.58 0.77 0.80 4.06 8.93 22
Other Current Liabilities		 - - 0.01 0.18 0.19 0.20 0.19 0.18 0.17
Total Noncurrent Liabilities		 0.00 0.00 0.02 0.07 0.07 15 35 37 98
Long-Term Debt		 - - - - 0.00 15 35 37 98
Other Noncurrent Operating Liabilities		 - - 0.00 0.07 0.06 0.06 0.06 0.23 0.05
Commitments & Contingencies		 0.00 0.00 - - - 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 5.61 31 25 19 12 69 134 140 116
Total Preferred & Common Equity		 5.61 31 25 19 12 69 134 140 116
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 5.61 31 25 19 12 69 134 140 116
Common Stock		 14 33 35 36 38 125 230 300 387
Retained Earnings		 -8.33 -2.01 -9.49 -17 -26 -56 -96 -160 -272

Quarterly Balance Sheets for Celcuity

This table presents Celcuity's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025
Total Assets		 65 165 154 142 188 293 273 218
Total Current Assets		 65 164 153 142 188 292 272 218
Cash & Equivalents		 57 34 32 26 31 30 13 16
Short-Term Investments		 - 124 114 108 146 253 251 189
Other Current Assets		 0.37 0.06 0.10 - 9.86 8.86 8.38 12
Plant, Property, & Equipment, net		 0.30 0.22 0.21 0.22 0.31 0.31 0.34 0.36
Total Noncurrent Assets		 0.30 0.55 0.50 0.45 0.35 0.31 0.26 0.17
Other Noncurrent Operating Assets		 0.30 0.55 0.50 0.45 0.35 0.31 0.26 0.17
Total Liabilities & Shareholders' Equity		 65 165 154 142 188 293 273 218
Total Liabilities		 22 42 43 49 54 116 123 131
Total Current Liabilities		 6.65 5.81 7.08 13 17 20 26 33
Accounts Payable		 3.17 2.57 3.02 5.63 5.28 6.20 9.16 9.93
Accrued Expenses		 3.28 3.04 3.87 6.89 11 13 17 23
Other Current Liabilities		 0.20 0.20 0.19 0.19 0.18 0.18 0.18 0.17
Total Noncurrent Liabilities		 15 36 36 37 38 96 97 99
Long-Term Debt		 15 35 36 37 38 96 97 99
Other Noncurrent Operating Liabilities		 0.11 0.36 0.32 0.27 0.18 0.14 0.10 0.01
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 44 123 110 93 134 177 150 87
Total Preferred & Common Equity		 44 123 110 93 134 177 150 87
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 44 123 110 93 134 177 150 87
Common Stock		 128 231 233 234 315 382 385 396
Retained Earnings		 -85 -108 -123 -141 -182 -205 -235 -309

Annual Metrics And Ratios for Celcuity

This table displays calculated financial ratios and metrics derived from Celcuity's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - - - - - - - -
Revenue Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Growth		 0.00% -79.65% -31.77% 3.12% -22.83% -202.98% -39.59% -69.77% -69.80%
EBIT Growth		 0.00% -78.85% -33.20% 1.57% -22.43% -196.73% -38.92% -68.14% -71.02%
NOPAT Growth		 0.00% -78.85% -33.25% 1.60% -22.43% -196.73% -38.92% -68.14% -71.02%
Net Income Growth		 0.00% -88.85% -19.66% 1.62% -28.74% -212.48% -36.36% -57.99% -75.26%
EPS Growth		 0.00% -61.54% 11.90% 2.70% -27.78% 0.00% 0.00% -1.89% -5.20%
Operating Cash Flow Growth		 0.00% -71.31% -22.80% 1.28% -19.12% -184.25% -77.28% -49.44% -55.11%
Free Cash Flow Firm Growth		 0.00% 0.00% -38.26% 8.73% -11.61% -203.72% -52.36% -47.85% -44.54%
Invested Capital Growth		 0.00% 79.45% 879.31% 19.20% -87.08% -1,404.10% 117.63% -2,361.88% -475.90%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 0.00% 0.00% -1.08% 1.01% 16.64% -28.63% -15.88% -14.14% -16.95%
EBIT Q/Q Growth		 0.00% 0.00% -1.59% 0.68% 16.05% -28.24% -15.61% -13.91% -17.29%
NOPAT Q/Q Growth		 0.00% 0.00% -1.63% 0.68% 16.05% -28.27% -15.61% -13.91% -17.29%
Net Income Q/Q Growth		 0.00% 0.00% -1.37% 0.22% 15.46% -29.12% -13.58% -12.86% -18.95%
EPS Q/Q Growth		 0.00% 0.00% -5.71% 1.37% -8.24% 0.00% 0.00% 0.00% -8.43%
Operating Cash Flow Q/Q Growth		 0.00% -8.94% -7.22% -3.17% -5.98% -24.65% -10.28% -20.24% -12.44%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% -0.63% 20.05% -35.03% -8.79% -20.82% -12.06%
Invested Capital Q/Q Growth		 0.00% 0.00% 80.92% 101.23% 10.78% 35.31% -84.17% 16.73% -24.86%
Profitability Metrics		 - - - - - - - - -
Gross Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profit (Net Income) Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent		 99.46% 105.02% 94.34% 94.29% 99.14% 104.41% 102.49% 96.30% 98.69%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 -58.99% -33.79% -26.37% -32.97% -61.12% -73.63% -39.88% -46.63% -87.54%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% -1,289.33% -1,073.77% -1,951.87% 0.00% -17,175.55% 0.00% 0.00%
Operating Return on Assets (OROA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Assets (ROA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)		 -58.99% -33.79% -26.37% -32.97% -61.12% -73.63% -39.88% -46.63% -87.54%
Return on Equity Simple (ROE_SIMPLE)		 -58.99% -19.92% -29.51% -38.14% -80.96% -43.09% -30.18% -45.63% -96.68%
Net Operating Profit after Tax (NOPAT)		 -2.33 -4.17 -5.55 -5.46 -6.69 -20 -28 -46 -79
NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)		 -16.60% -11.16% -6.85% -8.69% -18.34% -24.00% -12.59% -12.57% -23.13%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - -26.22% -37.16%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)		 -3.33 -5.95 -7.93 -7.81 -9.56 -28 -39 -66 -113
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -3.26 -5.85 -7.71 -7.47 -9.17 -28 -39 -66 -112
Valuation Ratios		 - - - - - - - - -
Price to Book Value (P/BV)		 0.00 6.09 9.61 5.65 8.06 2.86 1.62 2.52 4.20
Price to Tangible Book Value (P/TBV)		 0.00 6.09 9.61 5.65 8.06 2.86 1.62 2.52 4.20
Price to Revenue (P/Rev)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 463.66 160.60 1,138.08 0.00 496.84 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.21 0.26 0.27 0.85
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.21 0.26 0.27 0.85
Financial Leverage		 -1.05 -1.01 -0.99 -0.98 -0.98 -1.01 -1.00 -1.01 -1.10
Leverage Ratio		 1.08 1.03 1.02 1.04 1.07 1.23 1.29 1.34 1.71
Compound Leverage Factor		 1.07 1.08 0.96 0.98 1.06 1.28 1.32 1.29 1.69
Debt to Total Capital		 0.00% 0.00% 0.08% 0.00% 0.07% 17.55% 20.73% 20.95% 45.81%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.08% 0.00% 0.07% 17.55% 20.73% 20.95% 45.81%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 99.92% 100.00% 99.93% 82.45% 79.27% 79.05% 54.19%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 -0.53 -0.90 -0.56 -0.87
Net Debt to EBITDA		 0.00 0.00 3.23 0.00 1.27 2.51 3.44 2.18 1.23
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 -0.53 -0.90 -0.56 -0.87
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 -0.74 -1.27 -0.80 -1.23
Net Debt to NOPAT		 0.00 0.00 4.48 0.00 1.74 3.51 4.85 3.10 1.73
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 -0.74 -1.27 -0.80 -1.23
Altman Z-Score		 0.00 198.50 213.96 65.22 40.85 6.02 2.74 2.90 0.22
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - -
Current Ratio		 13.27 42.36 38.07 21.12 10.26 34.06 25.46 13.43 7.71
Quick Ratio		 13.15 41.86 37.59 20.77 9.98 33.64 24.50 12.73 7.41
Cash Flow Metrics		 - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -4.40 -6.09 -5.55 -6.20 -19 -29 -42 -61
Operating Cash Flow to CapEx		 -7,061.31% -2,062.97% -971.26% -1,577.77% -7,995.53% -24,953.86% -22,679.74% -55,110.66% -33,403.00%
Free Cash Flow to Firm to Interest Expense		 0.00 -9.74 -54,822.64 -34,932.75 -51,661.70 -14.92 -13.62 -7.96 -5.96
Operating Cash Flow to Interest Expense		 0.00 -10.96 -54,741.16 -37,727.74 -59,547.41 -16.09 -17.10 -10.10 -8.12
Operating Cash Flow Less CapEx to Interest Expense		 0.00 -11.49 -60,377.27 -40,118.94 -60,292.17 -16.16 -17.17 -10.12 -8.14
Efficiency Ratios		 - - - - - - - - -
Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Receivable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - -
Invested Capital		 -0.29 -0.06 0.47 0.56 0.07 -0.95 0.17 -3.78 -22
Invested Capital Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Increase / (Decrease) in Invested Capital		 0.00 0.23 0.53 0.09 -0.49 -1.02 1.11 -3.95 -18
Enterprise Value (EV)		 0.00 160 219 90 83 127 83 209 349
Market Capitalization		 0.00 191 244 109 94 197 217 353 486
Book Value per Share		 $0.89 $3.11 $2.50 $1.88 $1.14 $4.61 $8.65 $5.77 $3.11
Tangible Book Value per Share		 $0.89 $3.11 $2.50 $1.88 $1.14 $4.61 $8.65 $5.77 $3.11
Total Capital		 5.61 31 25 19 12 83 169 177 213
Total Debt		 0.00 0.00 0.02 0.00 0.01 15 35 37 98
Total Long-Term Debt		 0.00 0.00 0.02 0.00 0.01 15 35 37 98
Net Debt		 -5.91 -31 -25 -19 -12 -70 -134 -144 -137
Capital Expenditures (CapEx)		 0.04 0.24 0.63 0.38 0.09 0.08 0.16 0.10 0.25
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -0.44 -0.34 -0.34 -0.40 -0.66 -1.44 -0.28 -4.18 -22
Debt-free Net Working Capital (DFNWC)		 5.47 24 25 18 11 83 168 176 213
Net Working Capital (NWC)		 5.47 24 25 18 11 83 168 176 213
Net Nonoperating Expense (NNE)		 0.98 2.08 1.93 1.90 2.78 9.76 13 17 32
Net Nonoperating Obligations (NNO)		 -5.91 -31 -25 -19 -12 -70 -134 -144 -137
Total Depreciation and Amortization (D&A)		 0.07 0.10 0.22 0.34 0.39 0.57 0.61 0.38 1.46
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Adjustments		 - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.52) ($0.84) ($0.74) ($0.72) ($0.92) ($2.21) ($2.64) ($2.69) ($2.83)
Adjusted Weighted Average Basic Shares Outstanding		 6.31M 10.11M 10.21M 10.25M 10.30M 14.92M 15.42M 23.68M 39.45M
Adjusted Diluted Earnings per Share		 ($0.52) ($0.84) ($0.74) ($0.72) ($0.92) ($2.21) $0.00 ($2.69) ($2.83)
Adjusted Weighted Average Diluted Shares Outstanding		 6.31M 10.11M 10.21M 10.25M 10.30M 14.92M 21.69M 23.68M 39.45M
Adjusted Basic & Diluted Earnings per Share		 ($0.52) ($0.84) ($0.74) ($0.72) ($0.92) ($2.21) $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 6.31M 7.46M 10.12M 10.23M 10.27M 13.38M 21.69M 30.45M 37.84M
Normalized Net Operating Profit after Tax (NOPAT)		 -2.33 -4.17 -5.55 -5.46 -6.69 -20 -28 -46 -79
Normalized NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Pre Tax Income Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt Service Ratios		 - - - - - - - - -
EBIT to Interest Expense		 0.00 -13.18 -71,437.28 -49,089.94 -79,634.70 -22.46 -18.70 -12.43 -11.02
NOPAT to Interest Expense		 0.00 -9.23 -50,025.01 -34,362.96 -55,744.29 -15.72 -13.09 -8.70 -7.71
EBIT Less CapEx to Interest Expense		 0.00 -13.71 -77,073.39 -51,481.14 -80,379.46 -22.53 -18.78 -12.45 -11.04
NOPAT Less CapEx to Interest Expense		 0.00 -9.76 -55,661.12 -36,754.16 -56,489.05 -15.79 -13.17 -8.72 -7.74
Payout Ratios		 - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% -13.69% -0.04% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Celcuity

This table displays calculated financial ratios and metrics derived from Celcuity's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Growth		 -92.59% -86.24% -69.19% -58.07% -79.32% -71.08% -79.96% -60.54% -55.72% -82.53% -58.70%
EBIT Growth		 -90.07% -84.14% -67.13% -56.82% -77.55% -69.51% -79.27% -61.29% -57.64% -84.65% -60.64%
NOPAT Growth		 -90.07% -84.14% -67.13% -56.82% -77.55% -69.51% -79.27% -61.29% -59.06% -84.65% -60.64%
Net Income Growth		 -80.74% -71.49% -50.46% -46.46% -68.95% -62.75% -81.03% -62.62% -61.87% -94.46% -71.19%
EPS Growth		 0.00% 0.00% 0.00% 1.49% -10.67% 0.00% -16.36% 6.06% 15.66% -33.85% -34.38%
Operating Cash Flow Growth		 -129.87% -54.79% -116.88% 14.41% -36.96% -95.54% -32.64% -86.99% -61.31% -49.82% -110.06%
Free Cash Flow Firm Growth		 -317.22% -172.06% -259.29% -8.86% 23.41% -6.52% 31.67% 24.01% -6.76% 23.76% -36.75%
Invested Capital Growth		 172.03% 117.63% 163.50% -109.75% -530.07% -2,361.88% -618.49% -8,002.71% -284.08% -475.90% -222.28%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 -10.80% -9.47% -8.43% -20.19% -25.70% -4.44% -14.06% -7.21% -21.92% -22.42% 0.84%
EBIT Q/Q Growth		 -10.86% -9.35% -7.80% -19.99% -25.52% -4.40% -14.01% -7.95% -22.69% -22.28% 0.82%
NOPAT Q/Q Growth		 -10.86% -9.35% -7.80% -19.99% -25.52% -4.40% -14.01% -7.95% -23.79% -21.19% 0.82%
Net Income Q/Q Growth		 -9.37% -6.31% -3.08% -22.19% -26.16% -2.41% -14.66% -9.76% -25.59% -23.03% -0.94%
EPS Q/Q Growth		 -11.94% 0.00% 0.00% -20.00% -25.76% 21.69% 1.54% 3.13% -12.90% -24.29% 1.15%
Operating Cash Flow Q/Q Growth		 17.56% -1.85% -35.75% 24.91% -31.92% -45.42% 7.92% -5.85% -13.81% -35.06% -29.11%
Free Cash Flow Firm Q/Q Growth		 -18.96% 7.10% -28.93% 23.60% 16.30% -29.19% 17.29% 15.02% -17.59% 7.74% -48.33%
Invested Capital Q/Q Growth		 -18.18% -84.17% 634.35% -110.25% -3,507.56% 16.73% -68.33% -60.24% -71.01% -24.86% 5.80%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profit (Net Income) Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent		 102.35% 99.50% 95.15% 96.89% 97.39% 95.54% 96.08% 97.69% 100.00% 100.61% 102.39%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 -60.24% -39.88% -48.03% -60.01% -82.85% -46.63% -57.17% -57.59% -77.47% -87.54% -115.39%
Cash Return on Invested Capital (CROIC)		 -2,499.64% -17,175.55% -2,793.12% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Assets (ROA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)		 -60.24% -39.88% -48.03% -60.01% -82.85% -46.63% -57.17% -57.59% -77.47% -87.54% -115.39%
Return on Equity Simple (ROE_SIMPLE)		 -81.66% 0.00% -36.01% -44.49% -60.83% 0.00% -54.92% -46.74% -62.77% 0.00% -146.73%
Net Operating Profit after Tax (NOPAT)		 -7.45 -8.15 -8.78 -11 -13 -14 -16 -17 -21 -26 -25
NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)		 -5.82% -3.38% -3.40% -4.99% -7.40% -3.64% -4.48% -4.53% -6.61% -7.94% -9.47%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - -7.81% - - - -11.95% -13.66%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)		 -11 -12 -13 -15 -19 -20 -22 -24 -30 -36 -36
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -10 -11 -12 -15 -19 -20 -22 -24 -29 -36 -36
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 3.45 1.62 1.80 2.19 2.17 2.52 4.92 2.90 3.69 4.20 4.41
Price to Tangible Book Value (P/TBV)		 3.45 1.62 1.80 2.19 2.17 2.52 4.92 2.90 3.69 4.20 4.41
Price to Revenue (P/Rev)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 101.94 496.84 81.79 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.34 0.26 0.29 0.33 0.39 0.27 0.28 0.54 0.65 0.85 1.14
Long-Term Debt to Equity		 0.34 0.26 0.29 0.33 0.39 0.27 0.28 0.54 0.65 0.85 1.14
Financial Leverage		 -1.00 -1.00 -1.00 -0.99 -1.03 -1.01 -1.02 -1.04 -1.09 -1.10 -1.12
Leverage Ratio		 1.33 1.29 1.32 1.38 1.52 1.34 1.37 1.56 1.71 1.71 1.84
Compound Leverage Factor		 1.36 1.29 1.26 1.34 1.48 1.28 1.32 1.52 1.71 1.72 1.89
Debt to Total Capital		 25.65% 20.73% 22.35% 24.63% 28.21% 20.95% 21.93% 35.25% 39.30% 45.81% 53.20%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 25.65% 20.73% 22.35% 24.63% 28.21% 20.95% 21.93% 35.25% 39.30% 45.81% 53.20%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 74.35% 79.27% 77.64% 75.37% 71.79% 79.05% 78.07% 64.75% 60.70% 54.19% 46.80%
Debt to EBITDA		 -0.45 -0.90 -0.81 -0.73 -0.63 -0.56 -0.50 -1.13 -1.01 -0.87 -0.79
Net Debt to EBITDA		 1.27 3.44 2.78 2.23 1.69 2.18 1.85 2.20 1.75 1.23 0.86
Long-Term Debt to EBITDA		 -0.45 -0.90 -0.81 -0.73 -0.63 -0.56 -0.50 -1.13 -1.01 -0.87 -0.79
Debt to NOPAT		 -0.63 -1.27 -1.14 -1.03 -0.90 -0.80 -0.70 -1.61 -1.43 -1.23 -1.11
Net Debt to NOPAT		 1.78 4.85 3.92 3.16 2.39 3.10 2.63 3.13 2.47 1.73 1.21
Long-Term Debt to NOPAT		 -0.63 -1.27 -1.14 -1.03 -0.90 -0.80 -0.70 -1.61 -1.43 -1.23 -1.11
Altman Z-Score		 2.85 3.26 3.18 3.03 1.71 3.71 6.59 2.51 2.20 1.25 0.23
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 9.74 25.46 28.26 21.58 11.15 13.43 11.23 14.95 10.36 7.71 6.61
Quick Ratio		 8.65 24.50 27.12 20.65 10.54 12.73 10.64 14.50 10.04 7.41 6.25
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -9.97 -9.26 -12 -9.12 -7.64 -9.87 -8.16 -6.93 -8.15 -7.52 -11
Operating Cash Flow to CapEx		 -76,896.46% -8,460.30% -184,168.28% -199,053.40% -24,002.79% -56,686.51% -19,033.14% -28,109.63% -40,491.73% -61,507.42% -59,755.00%
Free Cash Flow to Firm to Interest Expense		 -18.54 -13.66 -9.61 -6.94 -5.57 -7.06 -5.83 -3.07 -2.44 -2.30 -3.51
Operating Cash Flow to Interest Expense		 -17.31 -13.98 -10.36 -7.35 -9.29 -13.27 -12.19 -7.99 -6.15 -8.48 -11.26
Operating Cash Flow Less CapEx to Interest Expense		 -17.33 -14.15 -10.37 -7.35 -9.33 -13.29 -12.25 -8.02 -6.16 -8.49 -11.28
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Receivable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 1.05 0.17 1.23 -0.13 -4.54 -3.78 -6.36 -10 -17 -22 -20
Invested Capital Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Increase / (Decrease) in Invested Capital		 2.52 1.11 3.16 -1.42 -5.59 -3.95 -7.59 -10 -13 -18 -14
Enterprise Value (EV)		 108 83 100 131 104 209 518 325 385 349 275
Market Capitalization		 150 217 222 241 202 353 658 512 552 486 383
Book Value per Share		 $2.91 $8.65 $5.68 $5.02 $4.21 $5.77 $4.39 $5.66 $4.04 $3.11 $2.33
Tangible Book Value per Share		 $2.91 $8.65 $5.68 $5.02 $4.21 $5.77 $4.39 $5.66 $4.04 $3.11 $2.33
Total Capital		 59 169 159 146 129 177 171 273 247 213 185
Total Debt		 15 35 35 36 37 37 38 96 97 98 99
Total Long-Term Debt		 15 35 35 36 37 37 38 96 97 98 99
Net Debt		 -42 -134 -122 -110 -97 -144 -140 -187 -167 -137 -107
Capital Expenditures (CapEx)		 0.01 0.11 0.01 0.00 0.05 0.03 0.09 0.06 0.05 0.05 0.06
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.57 -0.28 0.82 -0.52 -4.94 -4.18 -6.84 -11 -18 -22 -21
Debt-free Net Working Capital (DFNWC)		 58 168 158 146 129 176 171 272 246 213 185
Net Working Capital (NWC)		 58 168 158 146 129 176 171 272 246 213 185
Net Nonoperating Expense (NNE)		 3.44 3.43 3.16 4.05 5.18 5.04 5.87 6.72 8.75 11 12
Net Nonoperating Obligations (NNO)		 -42 -134 -122 -110 -97 -144 -140 -187 -167 -137 -107
Total Depreciation and Amortization (D&A)		 0.16 0.16 0.10 0.10 0.10 0.09 0.09 0.27 0.51 0.59 0.59
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.75) ($0.69) ($0.55) ($0.66) ($0.83) ($0.65) ($0.64) ($0.62) ($0.70) ($0.87) ($0.86)
Adjusted Weighted Average Basic Shares Outstanding		 14.94M 15.42M 21.68M 21.96M 22.12M 23.68M 33.61M 38.44M 42.79M 39.45M 43.05M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.00 ($0.66) ($0.83) ($0.65) ($0.64) ($0.62) ($0.70) ($0.87) ($0.86)
Adjusted Weighted Average Diluted Shares Outstanding		 15.46M 15.42M 21.96M 21.96M 22.12M 23.68M 33.61M 38.44M 42.79M 39.45M 43.05M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 15.46M 21.69M 21.96M 22.09M 24.20M 30.45M 31.23M 37.03M 37.13M 37.84M 37.87M
Normalized Net Operating Profit after Tax (NOPAT)		 -7.45 -8.15 -8.78 -11 -13 -14 -16 -17 -21 -26 -25
Normalized NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Pre Tax Income Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -19.80 -17.17 -10.10 -11.45 -13.77 -14.12 -16.06 -10.74 -8.91 -11.12 -11.35
NOPAT to Interest Expense		 -13.86 -12.02 -7.07 -8.01 -9.64 -9.88 -11.24 -7.52 -6.29 -7.79 -7.95
EBIT Less CapEx to Interest Expense		 -19.82 -17.33 -10.11 -11.45 -13.81 -14.14 -16.12 -10.77 -8.92 -11.14 -11.37
NOPAT Less CapEx to Interest Expense		 -13.88 -12.18 -7.08 -8.02 -9.68 -9.91 -11.31 -7.55 -6.31 -7.80 -7.97
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Key Financial Trends

Celcuity Inc. Financial Summary and Trends (2022 Q3 through 2025 Q1)

Celcuity Inc., a NASDAQ-listed diagnostics company, has exhibited consistent operating losses over the last several quarters, reflecting continued investment in research and development (R&D) and a lack of revenue generation. The analysis below highlights key financial trends across income statements, cash flow statements, and balance sheets from Q3 2022 through Q1 2025.

  • Substantial investment in Short-Term Investments nearing or exceeding $100 million consistently, indicating a strong cash buffer (e.g., $189M in Q1 2025, $251M in Q3 2024, maintaining liquidity).
  • Regular cash inflows from sale or maturity of investments providing financing for operations (e.g., $66.8M sale of investments in Q1 2025; prior quarters also show significant inflows).
  • Growth in total common equity, reflecting capital raises and retained investment; for example, equity rose from approximately $43.5M in Q3 2022 to $86.7M in Q1 2025.
  • Amortization and depreciation expenses are relatively modest compared to overall expenses, suggesting limited fixed asset or intangible asset burden.
  • No reported revenue during these periods, consistent with Celcuity’s focus on product development and clinical validation prior to commercialization.
  • Interest & investment income (around $2-$3 million quarterly) partially offsets interest expense (approximately $1.3-$3.2 million), but net other income remains negative or very small.
  • Net cash used in operating activities varies but remains significant in absolute terms, reflecting ongoing cash burn (e.g., -$35.9M in Q1 2025, -$27.8M in Q4 2024).
  • Fluctuations in accrued expenses and accounts payable in current liabilities suggest normal operating cycles.
  • Periodic equity issuance contributes to financing but with limited frequency and scale in recent periods.
  • Consistent operating losses quarter-over-quarter reaching $36.9M in Q1 2025, slightly higher than the $36.7M loss in Q4 2024, indicating no turnaround in profitability yet.
  • No revenue reported in any quarter, underscoring that Celcuity remains pre-commercial or early commercial without product sales at scale.
  • High R&D expenses increasing from $9.6M in Q3 2022 to over $32M in Q1 2025 highlight the cost intensity of product development.
  • Increasing long-term debt balance, rising from approximately $15M in Q3 2022 to $98.5M by Q1 2025, suggests growing leverage and potential financing risk.
  • Negative earnings per share (EPS) showing gradual decline from about -$0.55 in Q1 2023 to about -$0.86 in Q1 2025, indicating widening losses per share.
  • Net cash used in operating activities remains substantial, with no indication yet of reducing cash burn.
  • Increasing total liabilities rising from roughly $21.7M in Q3 2022 to $131.5M in Q1 2025, reflecting rising debt and current liabilities.

Summary: Celcuity Inc. operates as a development-stage biotechnology/diagnostics company heavily investing in R&D without yet generating revenue. While it maintains a strong short-term investment position ensuring liquidity, the company faces ongoing operating losses, growing leverage, and substantial cash burn. Retail investors should weigh the company's cash runway and research progress against the absence of revenues and increasing debt load when considering investment risks.

08/27/25 06:41 AMAI Generated. May Contain Errors.

Frequently Asked Questions About Celcuity's Financials

When does Celcuity's fiscal year end?

According to the most recent income statement we have on file, Celcuity's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Celcuity's net income changed over the last 8 years?

Celcuity's net income appears to be on an upward trend, with a most recent value of -$111.78 million in 2024, rising from -$3.31 million in 2016. The previous period was -$63.78 million in 2023. View Celcuity's forecast to see where analysts expect Celcuity to go next.

What is Celcuity's operating income?
Celcuity's total operating income in 2024 was -$113.27 million, based on the following breakdown:
  • Total Gross Profit: $0.00
  • Total Operating Expenses: $113.27 million
How has Celcuity's revenue changed over the last 8 years?

Over the last 8 years, Celcuity's total revenue changed from $0.00 in 2016 to $0.00 in 2024, a change of 0.0%.

How much debt does Celcuity have?

Celcuity's total liabilities were at $129.50 million at the end of 2024, a 151.7% increase from 2023, and a 28,978.6% increase since 2016.

How much cash does Celcuity have?

In the past 8 years, Celcuity's cash and equivalents has ranged from $2.64 million in 2017 to $84.29 million in 2021, and is currently $22.52 million as of their latest financial filing in 2024.

How has Celcuity's book value per share changed over the last 8 years?

Over the last 8 years, Celcuity's book value per share changed from 0.89 in 2016 to 3.11 in 2024, a change of 250.3%.


Related Companies

This page (NASDAQ:CELC) was last updated on 8/27/2025 by MarketBeat.com Staff
From Our Partners
Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...
Brownstone Research | Sponsoredtc pixel
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...
Goldco Precious Metals | Sponsoredtc pixel
Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...
The Oxford Club | Sponsoredtc pixel
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsoredtc pixel
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsoredtc pixel
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Paradigm Press | Sponsoredtc pixel
Out of 18,347 Cryptocurrencies... This is the ONLY One
The Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...
Crypto 101 Media | Sponsoredtc pixel
Trump set to Boost Social Security Checks by 400%?
If you're collecting or planning to collect social security... You should see this presentation about Presi...
InvestorPlace | Sponsoredtc pixel